These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 5098520)
1. [Late cutaneous porphyria: pathogenetic problems and special clinical features]. Szczepański A; Kaczyńska H Przegl Dermatol; 1971; 58(4):405-11. PubMed ID: 5098520 [No Abstract] [Full Text] [Related]
2. [Toxic hepato-cutaneous porphyria (occupational disease)]. Bopp C; Kosminsky B Med Cutan Ibero Lat Am; 1975; 3(4):271-9. PubMed ID: 1241082 [TBL] [Abstract][Full Text] [Related]
3. Severe cutaneous porphyria in a 12-year-old boy: hepatoerythropoietic or symptomatic porphyria? Day RS; Strauss PC Arch Dermatol; 1982 Sep; 118(9):663-7. PubMed ID: 7114869 [TBL] [Abstract][Full Text] [Related]
4. [Hyponatremia in a cirrhotic suffering from late cutaneous porphyria: a drug to avoid, demeclocycline]. Boissonnas A; Casassus P; Caquet R; Laroche C Nouv Presse Med; 1979 Jan; 8(3):210. PubMed ID: 122011 [No Abstract] [Full Text] [Related]
8. [State of the nervous system in late cutaneous porphyria]. Petrova EA Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(3):378-82. PubMed ID: 5027051 [No Abstract] [Full Text] [Related]
9. [Late cutaneous porphyria of scleroderma-like form in a woman]. Duperrat B; Golé L; Puissant A; Mascaro JM; Weisgerber C; Pasquiou C Bull Soc Fr Dermatol Syphiligr; 1965; 72(6):829-31. PubMed ID: 5882715 [No Abstract] [Full Text] [Related]
10. [The role of some chemical factors in the pathogenesis of late cutaneous porphyria]. Pankov BS Vestn Dermatol Venerol; 1968 Dec; 42(12):21-5. PubMed ID: 5737435 [No Abstract] [Full Text] [Related]
12. [Cutaneous late porphyria with sclerodermiform evolution]. Duperrat B; Puissant A; David V; Lachiver D Bull Soc Fr Dermatol Syphiligr; 1970; 77(6):877-80. PubMed ID: 5512041 [No Abstract] [Full Text] [Related]
13. [Porphyria in pregnancy]. Sommer J; Reich W; Brandt M; König EM Zentralbl Gynakol; 1983; 105(1):45-51. PubMed ID: 6829241 [TBL] [Abstract][Full Text] [Related]
14. [Laboratory approximation to the diagnosis and typification of porphyria]. Lagartera L; Fontanellas A; Muñoz-Ribero MC; Navarro S; Enríquez De Salamanca R An Med Interna; 2000 Nov; 17(11):609-13. PubMed ID: 11322037 [TBL] [Abstract][Full Text] [Related]
15. Cytochemical and ultrastructural changes in rat liver in experimental porphyria. I. Effects of a single injection of allylisopropylacetamide. Biempica L; Kosower NS; Nivikoff AB Lab Invest; 1967 Aug; 17(2):171-89. PubMed ID: 6053023 [No Abstract] [Full Text] [Related]
17. [Acute intermittent porphyria detected during treatment of malaria with chloroquine]. Gerwel M Pol Tyg Lek; 1980 Sep; 35(35):1351-2. PubMed ID: 7433216 [No Abstract] [Full Text] [Related]
18. [Drug therapy in gynecology and obstetrics in inducible porphyria]. Ippen H; Goerz G Gynakologe; 1994 Oct; 27(5):348-51. PubMed ID: 7821867 [No Abstract] [Full Text] [Related]
19. [Case of intermittent acute porphyria caused by occupational gas air pollutants]. Hrycek A; Badowski R Pol Tyg Lek; 1980 Jul; 35(27):1031-2. PubMed ID: 7422595 [No Abstract] [Full Text] [Related]
20. Oral arsenic treatment of leukemia and the risk of porphyria. Au WY; Tam S; Fong BM; Kwong YL Leuk Res; 2009 Apr; 33(4):598-600. PubMed ID: 18829106 [No Abstract] [Full Text] [Related] [Next] [New Search]